4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 3 | 5 | 28 | -18 | 20,204 |
| Gross Profit | 3 | 5 | 28 | -18 | 20,204 |
| Operating Expenses | 51,135 | 42,461 | 38,164 | 36,633 | 34,178 |
| Operating Income | -51,132 | -42,456 | -38,136 | -36,651 | -13,974 |
| Other Income | 7,289 | 7,503 | 5,735 | 4,368 | 3,718 |
| Pre-tax Income | -43,843 | -34,953 | -32,401 | -32,283 | -10,256 |
| Net Income Continuous | -43,843 | -34,953 | -32,401 | -32,283 | -10,256 |
| Net Income | $-43,843 | $-34,953 | $-32,401 | $-32,283 | $-10,256 |
| EPS Basic Total Ops | -0.79 | -0.63 | -0.66 | -0.69 | -0.24 |
| EPS Basic Continuous Ops | -0.79 | -0.63 | -0.66 | -0.69 | -0.24 |
| EPS Diluted Total Ops | -0.79 | -0.63 | -0.66 | -0.69 | -0.24 |
| EPS Diluted Continuous Ops | -0.79 | -0.63 | -0.66 | -0.69 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.79 | -0.63 | -0.66 | -0.77 | N/A |
| EBITDA(a) | $-52,182 | $-43,597 | $-37,720 | $-36,028 | $-13,130 |